Amarin Corporation
AMRN
#8541
Rank
A$0.40 B
Marketcap
A$19.13
Share price
-1.73%
Change (1 day)
-17.96%
Change (1 year)

Earnings for Amarin Corporation (AMRN)

Earnings in 2026 (TTM): -A$46.6 Million

According to Amarin Corporation 's latest financial reports the company's current earnings are A$0.21 Billion. In 2025 the company made an earning of -A$50.59 Million, an increase over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amarin Corporation from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$46.6 Million-7.89%
2025 -A$50.59 Million-53.31%
2024 -A$0.11 Billion43.84%
2023 -A$75.33 Million-48.3%
2022 -A$0.15 Billion-1019.36%
2021 A$15.84 M-165.44%
2020 -A$24.22 Million-23.25%
2019 -A$31.55 Million-80.68%
2018 -A$0.17 Billion112.25%
2017 -A$76.94 Million-28.23%
2016 -A$0.11 Billion-35.43%
2015 -A$0.17 Billion99.81%
2014 -A$83.09 Million-65.06%
2013 -A$0.24 Billion-0.38%
2012 -A$0.24 Billion-150.87%
2011 A$0.46 B-233.68%
2010 -A$0.36 Billion
2007 -A$54.79 Million44.04%
2006 -A$38.04 Million
2004 -A$20.55 Million-46.41%
2003 -A$38.35 Million-41.09%
2002 -A$65.09 Million813.31%
2001 -A$7.13 Million113.63%
2000 -A$3.34 Million
1998 -A$23.72 Million98.82%
1997 -A$11.93 Million-50.29%
1996 -A$24 Million-1321.43%
1995 A$1.96 M-94.53%
1994 A$35.92 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
A$8.38 B-19,287.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.57 B-47,190.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.04 B-32,249.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
A$0.33 B-861.73%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$3.18 B-7,392.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel